THE BUSINESS OF BIOTECH

59:23 24_01_BoB_1280x720_Ep254
Leading A tRNA Startup With Alltrna's Michelle Werner

On this week's Business of Biotech, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna Rose Welch, editorial and community director at Advancing RNA. Werner explains why a single engineered tRNA therapy h...

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Michelle Werner
Alltrna
PLAY
Mark Eisner
Vir Biotechnology
PLAY
Tolga Tanguler
Alnylam Pharmaceuticals
PLAY
Brian Lortie
Uniquity Bio
PLAY
Allan Shaw
PLAY
Sara Bonstein
Insmed
PLAY
David Sans
PLAY
Nima Farzan
Latigo Biotherapeutics
PLAY
Kasper Roet
QurAlis
PLAY

MEET YOUR HOST

Ben ComerBen Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.

Interested in joining us on air? Contact us